Statistical analysis plan for the Dex-CSDH trial: a randomised, double-blind, placebo-controlled trial of a 2-week course of dexamethasone for adult patients with a symptomatic chronic subdural haematoma

BACKGROUND: The incidence of chronic subdural haematoma (CSDH) is increasing. Although surgery remains the mainstay of management for symptomatic patients, uncertainty remains regarding the role of steroids. Hence, the Dex-CSDH trial was launched in the UK in 2015 aiming to determine whether, compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Allison, Annabel, Edlmann, Ellie, Kolias, Angelos G., Davis-Wilkie, Carol, Mee, Harry, Thelin, Eric P., Turner, Carole, Hutchinson, Peter J., Bond, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905057/
https://www.ncbi.nlm.nih.gov/pubmed/31822298
http://dx.doi.org/10.1186/s13063-019-3866-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905057/
https://www.ncbi.nlm.nih.gov/pubmed/31822298
http://dx.doi.org/10.1186/s13063-019-3866-6

Ejemplares similares